Evidence map›Paper›PMID 30941811›Full record

ReviewAdvanced materials (Deerfield Beach, Fla.)2019

2D Nanoclay for Biomedical Applications: Regenerative Medicine, Therapeutic Delivery, and Additive Manufacturing.

Akhilesh K Gaharwar, Lauren M Cross, Charles W Peak, Karli Gold, James K Carrow, Anna Brokesh, Kanwar Abhay Singh

Abstract readReview
In one paragraph

Review in Advanced materials (Deerfield Beach, Fla.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. High-Speed Embedded Ink Writing of Anatomic-Size Organ Constructs.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  20. Review

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Akhilesh K GaharwarBiomedical Engineering, Dwight Look College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID https://orcid.org/0000-0002-0284-0201
Lauren M CrossBiomedical Engineering, Dwight Look College of Engineering, Texas A&M University, College Station, TX, 77843, USA.
Charles W PeakBiomedical Engineering, Dwight Look College of Engineering, Texas A&M University, College Station, TX, 77843, USA.
Karli GoldBiomedical Engineering, Dwight Look College of Engineering, Texas A&M University, College Station, TX, 77843, USA.
James K CarrowBiomedical Engineering, Dwight Look College of Engineering, Texas A&M University, College Station, TX, 77843, USA.
Anna BrokeshBiomedical Engineering, Dwight Look College of Engineering, Texas A&M University, College Station, TX, 77843, USA.
Kanwar Abhay SinghBiomedical Engineering, Dwight Look College of Engineering, Texas A&M University, College Station, TX, 77843, USA.

Funding

Mineralomics: Designing mineral based therapeutics to control and direct cell functionDP2EB026265 · NIBIB · TEXAS ENGINEERING EXPERIMENT STATION · PI GAHARWAR, AKHILESH K. · 2017 to 2021
$2.4M
National Institute of Biomedical Imaging and Bioengineering (NIBIB)National Institutes of HealthNational Science Foundation (NSF)NIBIB NIH HHS DP2 EB026265
6 · The paper itself

Abstract

Clay nanomaterials are an emerging class of 2D biomaterials of interest due to their atomically thin layered structure, charged characteristics, and well-defined composition. Synthetic nanoclays are plate-like polyions composed of simple or complex salts of silicic acids with a heterogeneous charge distribution and patchy interactions. Due to their biocompatible characteristics, unique shape, high surface-to-volume ratio, and charge, nanoclays are investigated for various biomedical applications. Here, a critical overview of the physical, chemical, and physiological interactions of nanoclay with biological moieties, including cells, proteins, and polymers, is provided. The state-of-the-art biomedical applications of 2D nanoclay in regenerative medicine, therapeutic delivery, and additive manufacturing are reviewed. In addition, recent developments that are shaping this emerging field are discussed and promising new research directions for 2D nanoclay-based biomaterials are identified.

Indexed as

AnimalsBiocompatible MaterialsClayDrug Delivery SystemsHumansNanostructuresPolymersPrinting, Three-DimensionalProteinsRegenerative MedicineSilicatesTissue EngineeringTissue ScaffoldsBiocompatible MaterialsClaylaponitePolymersProteinsSilicates2D nanomaterials3D printingbioprintingdrug deliverynanoclaynanosilicatestissue engineering

Identifiers

PMID30941811
PMCPMC6546555

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.